🧬Tidera Health
⚕️

Educational tool only. Does not confirm eligibility or provide medical advice. Always consult your physician before pursuing any trial.

NeurologyICD-10: G35

Find Recruiting Clinical Trials for Multiple Sclerosis

Search RRMS, PPMS, SPMS, and progressive MS trials matched to your disease type and relapse history.

🔍 Search Multiple Sclerosis Trials →

About Multiple Sclerosis

Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system in which the immune system attacks the myelin sheath. MS subtypes include relapsing-remitting MS (RRMS), secondary progressive MS (SPMS), primary progressive MS (PPMS), and clinically isolated syndrome (CIS). Disease-modifying therapies range from interferon beta and glatiramer acetate to high-efficacy agents like natalizumab, ocrelizumab, and ofatumumab.

What Types of Multiple Sclerosis Clinical Trials Exist?

MS clinical trials test new disease-modifying therapies, remyelination strategies, neuroprotective agents, and B-cell depleting antibodies. Eligibility commonly requires specific MS subtype, EDSS score range, relapse history, and prior DMT exposure.

Find Recruiting Multiple Sclerosis Trials Near You

Enter your profile and we'll search ClinicalTrials.gov in real time — matching trials to your age, location, and treatment history. Free, no account required.

Search Multiple Sclerosis Trials →

Data from ClinicalTrials.gov · Updated in real time · Educational use only

Frequently Asked Questions

What clinical trials are available for multiple sclerosis?
Recruiting MS trials include new B-cell depleting agents, BTK inhibitors, remyelination therapies, neuroprotective compounds, and progressive MS studies. Subtype (RRMS vs. progressive) strongly affects eligibility.
What is the difference between RRMS and progressive MS trials?
RRMS trials focus on reducing relapses and new MRI lesions. Progressive MS trials (PPMS, SPMS) target disability accumulation and neuroprotection, historically a harder endpoint with fewer approved options.
Does my current MS medication affect trial eligibility?
Yes. Many MS trials require washout periods from prior disease-modifying therapies, particularly high-efficacy agents. Eligibility depends on which DMT you are on and for how long.

Data source: All clinical trial information is sourced from ClinicalTrials.gov, the official U.S. registry maintained by the National Library of Medicine. Tidera Health is an independent educational platform and is not affiliated with ClinicalTrials.gov or the National Library of Medicine. Always verify trial details directly with the research coordinator or your physician.